Cargando…
Where to go with new expensive treatments in NSCLC.
Autores principales: | Webb, A., O'Brien, M. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062890/ https://www.ncbi.nlm.nih.gov/pubmed/9683287 |
Ejemplares similares
-
Maternal sleep position: what do we know where do we go?
por: O’Brien, Louise M, et al.
Publicado: (2015) -
The behavioural epidemiology of sedentary behaviour in inflammatory arthritis: where are we, and where do we need to go?
por: Fenton, Sally A M, et al.
Publicado: (2023) -
Where is crystallography going?
por: Grimes, Jonathan M., et al.
Publicado: (2018) -
Strengthening regulatory systems for medicines in a changed world: where do we go from here?
por: O'Brien, Julie, et al.
Publicado: (2021) -
Expensive Treatment
Publicado: (1883)